Key Board Approvals

Divestment of Medcords Healthcare Solutions Private Limited Stake:

  • Approved divestment of entire 14.18% holding in Medcords Healthcare Solutions Private Limited on fully converted & diluted basis
  • Divestment to be executed through wholly-owned subsidiary Startup Investments (Holding) Limited (SIHL)
  • Full impairment provision against this investment was booked in FY 2023-24
  • Post-divestment, Medcords will cease to be a Joint Venture of the Company
  • Sale agreement to be entered into within 30 days from Board approval (by November 27, 2026)
  • Expected completion date: January 27, 2027
  • Consideration: Approximately ₹5,000
  • Buyer: Mr. Shreyans Mehta (Director and Promoter of Medcords)
  • Transaction does not qualify as Related Party Transaction
  • Medcords contributed NIL to Total Income, Networth, Turnover, and Revenue in FY 2025-26 due to prior impairment

Divestment of Unnati Online Private Limited Stake:

  • Approved divestment of entire 31.64% holding in Unnati Online Private Limited on fully converted & diluted basis (excluding ESOP Pool)
  • Divestment to be executed through wholly-owned subsidiary Startup Investments (Holding) Limited (SIHL)
  • Full impairment provision against this investment was booked in FY 2019-20
  • Post-divestment, Unnati Online will cease to be an Associate Company of the Company
  • Sale agreement to be entered into within 30 days from Board approval (by November 27, 2026)
  • Expected completion date: January 27, 2027
  • Consideration: Approximately ₹5,000
  • Buyers: Mr. Eral Ravi and Mr. Aashutosh Chaudhary (Directors and Promoters of Unnati Online)
  • Transaction does not qualify as Related Party Transaction
  • Unnati Online contributed NIL to Total Income, Networth, Turnover, and Revenue in FY 2025-26 due to prior impairment

Investment in Redstart Labs (India) Limited:

  • Approved investment of approximately ₹150 crores in Redstart Labs (India) Limited
  • Redstart is a wholly-owned subsidiary of the Company (100% ownership on fully converted and diluted basis)
  • Purpose: To meet working capital requirements, explore investment opportunities, and other general purposes
  • Investment structure: Cash consideration for equity shares of face value ₹10 each
  • Investment to be made in one or more tranches depending on Redstart's fund requirements
  • Completion timeframe: Within 18 months from approval (by April 28, 2028)
  • Post-investment, Redstart remains wholly-owned subsidiary
  • Redstart financials as of March 31, 2026: Turnover - Nil, PAT - (₹2.99 crores), Networth - ₹76.93 crores
  • Business: Direct/indirect investments in tech companies, internet services, software development, consultancy, technical support
  • Date of incorporation: July 7, 2020
  • Country of presence: India
  • Last three years turnover: Nil for FY 2023-24, 2024-25, and 2025-26

Audit Committee Reconstitution:

  • Based on Nomination & Remuneration Committee recommendation
  • Mr. Naresh Chand Gupta, Additional Director (Independent Category), inducted as member of Audit Committee
  • Effective date: October 29, 2026
  • Post-reconstitution Audit Committee composition:
  • Mr. Sanjiv Sachar (Independent Director) - Chairman
  • Ms. Geeta Mathur (Independent Director) - Member
  • Ms. Radha Rajappa (Independent Director) - Member
  • Mr. Naresh Chand Gupta (Independent Director) - Member

Meeting Details

  • Board Meeting commenced at 10:30 a.m. on October 28, 2026
  • Above items considered and approved at 12:20 p.m.
  • Meeting continued for remaining agenda items and expected to end around 01:30 p.m.

Additional Information

  • Intimation uploaded on company website: www.infoedge.in
  • Signed by Jaya Bhatia, Company Secretary & Compliance Officer